CNS Summit (Collaborating for Novel Solutions)

Boston, MA

November 7 - November 10, 2021

Boston, MA |

CNS Summit.png

Now in our 12th year, we are excited to announce that we will bring the fun and excitement, the sense of community, discovering new technologies, meeting interesting new people and collaborating to you year round.

More than an annual event over 4 days, CNS Summit delivers programing, social events, networking, sponsorship opportunities and some of the fun -  brought to you throughout the year.

Parexel is proud to be an Executive Patron Sponsor at this event.

Presentation details:

Tuesday, November 9 from 1pm-1:50pm
A Collaborative Approach to deliver a Patients-First Focus for DCTs
The future is now and Hybrid Clinical Trials are no longer considered innovative. They are now just the way research is conducted — enabling biopharma companies and CROs to meet patients where it works best for them, improving their experience and ultimately creating efficiencies in the process. At the same time decentralization is broadening access to a larger and potentially more diverse patient pool than was previously possible. With the evolution of clinical trial technologies and services leading to a further increase in remote trial activities, the ability to collaborate across a variety of stakeholders to develop best-in-class partnerships and scale capabilities in support of the patient is key. This spotlight session will examine the essential requirements for DCT success to support the patients through the clinical trial process and what good looks like from the patient perspective.
Moderator: Jamie Macdonald, CEO, Parexel
Jake Elkins, MD, SVP, Development Sciences, Sarepta Therapeutics
Tony Clapsis, VP, CVS Clinical Trial Services
Deena Bernstein, Former Site Owner, SCRS Leadership Council Member, VP, Customer Success, Datacubed Health
Maimah Karmo, Founder/CEO, Tigerlily Foundation (Tigerlily)

Monday, Nov 8 from 1pm-1:50pm
Opportunities and Challenges of Collecting Wearable Data in Decentralized Clinical Trials
Panelist: Keith Wenzel, Senior Business Operations Director


We are always available for a conversation.


We are always available for a conversation.


Communication Preference

Communication Preference